BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31262715)

  • 1. Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis.
    Wang R; Tao B; Fan Q; Wang S; Chen L; Zhang J; Hao Y; Dong S; Wang Z; Wang W; Cai Y; Li X; Bao T; Wang X; Qiu X; Wang K; Mo X; Kang Y; Wang Z
    EBioMedicine; 2019 Jul; 45():108-123. PubMed ID: 31262715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis.
    Jiang M; Wu N; Xu B; Chu Y; Li X; Su S; Chen D; Li W; Shi Y; Gao X; Zhang H; Zhang Z; Du W; Nie Y; Liang J; Fan D
    Theranostics; 2019; 9(18):5359-5373. PubMed ID: 31410220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway.
    Pan J; Fan Z; Wang Z; Dai Q; Xiang Z; Yuan F; Yan M; Zhu Z; Liu B; Li C
    J Exp Clin Cancer Res; 2019 Feb; 38(1):52. PubMed ID: 30717785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells.
    Tao BB; Liu SY; Zhang CC; Fu W; Cai WJ; Wang Y; Shen Q; Wang MJ; Chen Y; Zhang LJ; Zhu YZ; Zhu YC
    Antioxid Redox Signal; 2013 Aug; 19(5):448-64. PubMed ID: 23199280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding.
    Jay AG; Chen AN; Paz MA; Hung JP; Hamilton JA
    J Biol Chem; 2015 Feb; 290(8):4590-4603. PubMed ID: 25555908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous lipids promote the growth of breast cancer cells via CD36.
    Zhao J; Zhi Z; Wang C; Xing H; Song G; Yu X; Zhu Y; Wang X; Zhang X; Di Y
    Oncol Rep; 2017 Oct; 38(4):2105-2115. PubMed ID: 28765876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of one or more intrachain disulphide bonds is required for the intracellular processing and transport of CD36.
    Gruarin P; Sitia R; Alessio M
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):635-42. PubMed ID: 9371725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hydrogen sulfide in secondary neuronal injury.
    Wang JF; Li Y; Song JN; Pang HG
    Neurochem Int; 2014 Jan; 64():37-47. PubMed ID: 24239876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2.
    Yang G; Zhao K; Ju Y; Mani S; Cao Q; Puukila S; Khaper N; Wu L; Wang R
    Antioxid Redox Signal; 2013 May; 18(15):1906-19. PubMed ID: 23176571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD36: The Bridge between Lipids and Tumors.
    Zhou X; Su M; Lu J; Li D; Niu X; Wang Y
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38276607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613.
    Hourihan JM; Kenna JG; Hayes JD
    Antioxid Redox Signal; 2013 Aug; 19(5):465-81. PubMed ID: 23145493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
    Ladanyi A; Mukherjee A; Kenny HA; Johnson A; Mitra AK; Sundaresan S; Nieman KM; Pascual G; Benitah SA; Montag A; Yamada SD; Abumrad NA; Lengyel E
    Oncogene; 2018 Apr; 37(17):2285-2301. PubMed ID: 29398710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD36: an emerging therapeutic target for cancer and its molecular mechanisms.
    Ruan C; Meng Y; Song H
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1551-1558. PubMed ID: 35224665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice.
    Drover VA; Nguyen DV; Bastie CC; Darlington YF; Abumrad NA; Pessin JE; London E; Sahoo D; Phillips MC
    J Biol Chem; 2008 May; 283(19):13108-15. PubMed ID: 18332148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36 tango in cancer: signaling pathways and functions.
    Wang J; Li Y
    Theranostics; 2019; 9(17):4893-4908. PubMed ID: 31410189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36.
    Momken I; Chabowski A; Dirkx E; Nabben M; Jain SS; McFarlan JT; Glatz JF; Luiken JJ; Bonen A
    Biochem J; 2017 Jan; 474(1):149-162. PubMed ID: 27827305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway.
    Yang P; Su C; Luo X; Zeng H; Zhao L; Wei L; Zhang X; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Cancer Lett; 2018 Dec; 438():76-85. PubMed ID: 30213558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocytes fuel gastric cancer omental metastasis
    Tan Y; Lin K; Zhao Y; Wu Q; Chen D; Wang J; Liang Y; Li J; Hu J; Wang H; Liu Y; Zhang S; He W; Huang Q; Hu X; Yao Z; Liang B; Liao W; Shi M
    Theranostics; 2018; 8(19):5452-5468. PubMed ID: 30555557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-Induced CD36 Expression in Gastric Cancer Cells Promotes Peritoneal Metastasis via Fatty Acid Uptake.
    Aoki T; Kinoshita J; Munesue S; Hamabe-Horiike T; Yamaguchi T; Nakamura Y; Okamoto K; Moriyama H; Nakamura K; Harada S; Yamamoto Y; Inaki N; Fushida S
    Ann Surg Oncol; 2023 May; 30(5):3125-3136. PubMed ID: 36042102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.